1.Rehabilitation management of a patient with median nerve entrapment from venipuncture-associated hematoma in dengue hemorrhagic fever: A case report
Jeffrey S. Arboleda ; Joycie Eulah H. Abiera ; Khariz S. Anarna
Acta Medica Philippina 2024;58(20):121-126
Dengue hemorrhagic fever is a severe form of dengue presenting commonly with bleeding diathesis, but rarely with peripheral nervous system manifestations. Proximal median neuropathy comprises 1% of upper limb compression syndromes, and this case is the first to report injury to the proximal median nerve due to compression from hematoma formation. This case report presents the rehabilitation process of a 25-year-old Filipino female median nerve entrapment from venipuncture-associated hematoma presenting as burning sensation on the medial elbow, forearm and hand, weak flexion movement of her left thumb, index, and middle fingers. The patient was managed conservatively with pain medications, range of motion, gross and fine motor, and sensory re-education exercises. At 12 months, there was partial but functional recovery of median motor distribution and full recovery of median sensory distribution, as evidenced by improved sensory nerve action potential conduction velocity and amplitude, and compound motor action potential conduction velocity, with persistent decreased amplitude at 50%, and decrease in cross-sectional area of the left median nerve.
This paper highlights the functional outcomes of a conservatively managed median nerve entrapment from venipuncture hematoma from dengue hemorrhagic fever. This case report also emphasizes that in the presence of severe bleeding risk of surgery in the background of severe thrombocytopenia, timely rehabilitation medicine referral with monitoring through clinical evaluation, musculoskeletal ultrasound, and electrodiagnostic study presents a viable alternative in the management of compression neuropathy.
Dengue Hemorrhagic Fever ; Severe Dengue ; Nerve Conduction Studies ; Rehabilitation
2.Global Epidemic of Ebola Virus Disease and the Importation Risk into China: An Assessment Based on the Risk Matrix Method.
Wei Jing SHANG ; Wen Zhan JING ; Jue LIU ; Min LIU
Biomedical and Environmental Sciences 2023;36(1):86-93
OBJECTIVE:
To analyze the global epidemic status of the Ebola virus disease (EVD) and assess the importation risk into China.
METHODS:
Data from World Health Organization reports were used. We described the global epidemic status of EVD from 1976-2021, and assessed and ranked the importation risk of EVD from the disease-outbreaking countries into China using the risk matrix and Borda count methods, respectively.
RESULTS:
From 1976-2021, EVD mainly occurred in western and central Africa, with the highest cumulative number of cases (14,124 cases) in Sierra Leone, and the highest cumulative fatality rate (85%) in the Congo. Outbreaks of EVD have occurred in the Democratic Republic of the Congo and Guinea since 2018. The importation risk into China varies across countries with outbreaks of disease. The Democratic Republic of the Congo had an extremely high risk (23 Borda points), followed by Guinea and Liberia. Countries with a moderate importation risk were Nigeria, Uganda, Congo, Sierra Leone, Mali, and Gabon, while countries with a low importation risk included Sudan, Senegal, and C
Humans
;
Hemorrhagic Fever, Ebola/prevention & control*
;
Epidemics
;
Disease Outbreaks/prevention & control*
;
Guinea/epidemiology*
;
Sierra Leone/epidemiology*
;
China/epidemiology*
3.Distribution of monocyte subsets and their surface CD31 intensity are associated with disease course and severity of hemorrhagic fever with renal syndrome.
Xiaozhou JIA ; Chunmei ZHANG ; Fenglan WANG ; Yanping LI ; Ying MA ; Yusi ZHANG ; Kang TANG ; Ran ZHUANG ; Yun ZHANG ; Yan ZHANG
Chinese Journal of Cellular and Molecular Immunology 2023;39(5):439-444
Objective To investigate the relationship between disease courses and severity and monocyte subsets distribution and surface CD31 intensity in patients of hemorrhagic fever with renal syndrome (HFRS). Methods Peripheral blood samples from 29 HFRS patients and 13 normal controls were collected. The dynamic changes of classical monocyte subsets (CD14++CD16-), intermediated monocyte subsets (CD14++CD16+) and non-classical monocyte subsets (CD14+CD16++) and the mean fluorescent intensity (MFI) of CD31 on monocyte subsets were detected by multiple-immunofluorescent staining and flow cytometry. Results In acute phase of HFRS, the ratio of classical monocyte subsets to total monocytes was dramatically decreased compared to convalescent phase and normal control. It was still much lower in convalescent phase compared to normal controls. The ratio of classical monocyte subsets to total monocytes were decreased in HFRS patients compared to that in normal control, whereas there was no difference between severe/critical groups and mild/moderate groups. On the contrary, the ratio of intermediate monocyte subsets to total monocytes in acute phase of HFRS was significantly increased compared to convalescent phase and normal control. The ratio of intermediate monocyte subsets to total monocytes were increased in HFRS patients compared to that in normal control, whereas no difference was found between severe/critical groups and mild/moderate groups. Phases or severity groups had no difference in ratio of non-classical monocyte subsets to total monocytes. Additionally, the ratio of classical monocyte subsets had a tendency to decline and that of intermediate monocyte subsets showed an increase both to total monocytes between the acute and convalescent phases in 11 HFRS patients with paired-samples. Moreover, in acute phase of HFRS, the mean fluorescent intensity (MFI) of CD31 on three monocyte subsets all decreased, specifically classical monocyte subsets showed the highest MFI of CD31 while the normal control reported the highest MFI of CD31 in non-classical monocyte subsets. In convalescent phase, the MFI of CD31 on classical and intermediated monocyte subsets were both lower than that of normal control, while MFI of CD31 was still significantly lower than normal control on non-classical monocyte subsets. Finally, MFI of CD31 on classical and intermediated monocyte subsets in severe/critical group were both lower than those in mild/moderate group, showing no statistical difference in MFI of CD31 on non-classical monocyte subset across groups of different disease severity. Conclusion The ratio of classical and intermediated monocyte subsets to total monocytes are correlated with the course of HFRS, and so are the surface intensity of CD31 on these monocyte subsets with the disease course and severity. The surface intensity of CD31 on non-classical monocyte subsets, however, is correlated only with the course of the disease. Together, the underlying mechanisms for the observed changes in monocyte subsets in HFRS patients should be further investigated.
Humans
;
Monocytes
;
Lipopolysaccharide Receptors
;
Hemorrhagic Fever with Renal Syndrome
;
Receptors, IgG
;
Disease Progression
4.Spatial Heterogeneity and Influencing Factors of HFRS Epidemics in Rural and Urban Areas: A Study in Guanzhong Plain of Shaanxi Province, China.
Ling Li ZHU ; Yan Ping LI ; Liang LU ; Shu Juan LI ; Hong Yan REN
Biomedical and Environmental Sciences 2022;35(11):1012-1024
OBJECTIVE:
The Guanzhong Plain of Shaanxi Province is a severely afflicted hemorrhagic fever with renal syndrome (HFRS) epidemic area, while HFRS prevalence has decreased in most epidemic areas in China. Little information is available regarding the leading fine-scale influencing factors in this highly HFRS-concentrated area and the roles of natural environmental and socioeconomic factors. To investigate this, two regions in the Guanzhong Plain, that is, the Chang'an District and Hu County, with similar geographical environments, different levels of economic development, and high epidemic prevalence, were chosen as representative areas of the HFRS epidemic.
METHODS:
Maximum entropy models were constructed based on HFRS cases and fine-scale influencing factors, including meteorological, natural environmental, and socioeconomic factors, from 2014 to 2016.
RESULTS:
More than 95% of the HFRS cases in the study area were located in the northern plains, which has an altitude of less than 800 m, with topography contributed 84.1% of the impact on the spatial differentiation of the HFRS epidemic. In the northern plains, precipitation and population density jointly affected the spatial differentiation of the HFRS epidemic, with contribution rates of 60.7% and 28.0%, respectively. By comparing the influencing factors of the northern plains of Chang'an District and Hu County, we found that precipitation and the normalized difference vegetation index (NDVI) dominated the HFRS epidemic in the relatively developed Chang'an District, while land-use type, temperature, precipitation and population density dominated the HFRS epidemic in the relatively undeveloped Hu County.
CONCLUSION
Topography was the primary key factor for HFRS prevalence in the Chang'an District and Hu County, and the spatial differentiation of HFRS was dominated by precipitation and population density in the northern plains. Compared with the influencing factors of the relatively developed Chang'an District, the developing Hu County was more affected by socioeconomic factors. When formulating targeted HFRS epidemic prevention and control strategies in the targeted areas, it is crucial to consider the local economic development state and combine natural environmental factors, including the meteorological environment and vegetation coverage.
Humans
;
Hemorrhagic Fever with Renal Syndrome/epidemiology*
;
China/epidemiology*
;
Epidemics
;
Socioeconomic Factors
;
Altitude
5.A Study on the Febrile Illness in Autumn among Farmers in Gyeongju-si: Scrub typhus, Leptospirosis, HFRS
Dong Seob KIM ; Dilaram ACHARYA ; Seok Ju YOO ; Ji Hyuk PARK ; Kwan LEE
Journal of Agricultural Medicine & Community Health 2019;44(1):1-10
OBJECTIVES: This study aimed to assess the status of Scrub typhus, Leptospirosis and HFRS(hemorrhagic fever with renal syndrome) among farmers with febrile illness. METHODS: We involved a total of 841 farmers who had febrile illness(508 and 333 village residents were, respectively, three and four district of Gyeongju city) selected during autumn of 2014 and 2015. Data were collected by survey questionnaires and blood sample examination. RESULTS: Serum response rate for Scrub typhus and Leptospirosis was 1.5% each and 1.9% for HFRS. Serum response rate for Scrub typhus was significantly higher for tick-bite cases(38.5%), while Leptospirosis was significantly higher for those who were in fruit–planting work(23.1%). Similarly, serum response rate was significantly higher for HFRS who were working in venyl green house work(25.0%). CONCLUSIONS: Government authority should develop effective and efficient preventive strategies to create awareness of infectious diseases among farmers. Extending information, education and communication be reached to farmers that could change their perception and help early diagnosis and treatment and reduce the disease burden and its complication.
Communicable Diseases
;
Early Diagnosis
;
Education
;
Farmers
;
Fever
;
Gyeongsangbuk-do
;
Hemorrhagic Fever with Renal Syndrome
;
Leptospirosis
;
Risk Factors
;
Scrub Typhus
6.Recent Increase of Human Granulocytic Anaplasmosis and Co-Infection with Scrub Typhus or Korean Hemorrhagic Fever with Renal Syndrome in Korea
Dae Hyuk HEO ; Joo Hee HWANG ; Seung Hee CHOI ; Mir JEON ; Ju Hyung LEE ; Jae Hoon LEE ; Seon Do HWANG ; Kyeong Ah LEE ; Seung Hun LEE ; Chang Seop LEE
Journal of Korean Medical Science 2019;34(11):e87-
We report 17 patients with human granulocytic anaplasmosis between January 2015 and September 2018 at two tertiary university hospitals in Korea. Monthly incidence peaked in May and June. Among these patients, we identified three who were co-infected with scrub typhus, and one patient with hemorrhagic fever with renal syndrome.
Anaplasmosis
;
Animals
;
Coinfection
;
Hemorrhagic Fever with Renal Syndrome
;
Hospitals, University
;
Humans
;
Incidence
;
Korea
;
Scrub Typhus
7.Introduction of Vaccinomics to Develop Personalized Vaccines in Light of Changes in the Usage of Hantaan Virus Vaccine (Hantavax®) in Korea
Korean Journal of Preventive Medicine 2019;52(5):277-280
The Ministry of Food and Drug Safety of Korea made an official announcement in March 2018 that the total number of inoculations of Hantaan virus vaccine (Hantavax®) would change from 3 to 4. Some aspects of this decision remain controversial. Based on the characteristics of Hantaan virus (HTNV) and its role in the pathogenesis of hemorrhagic fever with renal syndrome, it might be difficult to develop an effective and safe HTNV vaccine through the isolate-inactivate-inject paradigm. With the development of high-throughput ‘omics’ technologies in the 21st century, vaccinomics has been introduced. While the goal of vaccinomics is to develop equations to describe and predict the immune response, it could also serve as a tool for developing new vaccine candidates and individualized approaches to vaccinology. Thus, the possibility of applying the innovative field of vaccinomics to develop a more effective and safer HTNV vaccine should be considered.
Hantaan virus
;
Hemorrhagic Fever with Renal Syndrome
;
Humans
;
Immunogenetics
;
Korea
;
Precision Medicine
;
Vaccines
;
Vaccines, Synthetic
8.Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo.
Yun-Jia NING ; Zhenyu KANG ; Jingjun XING ; Yuan-Qin MIN ; Dan LIU ; Kuan FENG ; Manli WANG ; Fei DENG ; Yiwu ZHOU ; Zhihong HU ; Hualin WANG
Protein & Cell 2018;9(4):389-393
Adenoviridae
;
genetics
;
Ebolavirus
;
genetics
;
pathogenicity
;
Gene Transfer Techniques
;
Genetic Vectors
;
therapeutic use
;
Glycoproteins
;
genetics
;
HEK293 Cells
;
Hemorrhagic Fever, Ebola
;
genetics
;
pathology
;
virology
;
Humans
;
Inflammation
;
genetics
;
pathology
;
virology
;
Mucins
;
genetics
;
Transfection
;
Viral Envelope Proteins
;
genetics
9.Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein.
Baek Sang HAN ; Ho Young JANG ; Trina RACINE ; Xiangguo QIU ; Jeong Im SIN
Clinical and Experimental Vaccine Research 2018;7(2):119-128
PURPOSE: The goal of this study was to purify and characterize Ebola virus glycoprotein (GP)-specific IgG antibodies from hybridoma clones. MATERIALS AND METHODS: For hybridoma production, mice were injected by intramuscular-electroporation with GP DNA vaccines, and boosted with GP vaccines. The spleen cells were used for producing GP-specific hybridoma. Enzyme-linked immunosorbent assay, Western blot assay, flow cytometry, and virus-neutralizing assay were used to test the ability of monoclonal IgG antibodies to recognize GP and neutralize Ebola virus. RESULTS: Twelve hybridomas, the cell supernatants of which displayed GP-binding activity by enzyme-linked immunosorbent assay and the presence of both IgG heavy and light chains by Western blot assay, were chosen as a possible IgG producer. Among these, five clones (C36-1, D11-3, D12-1, D34-2, and E140-2) were identified to secrete monoclonal IgG antibodies. When the monoclonal IgG antibodies from the 5 clones were tested for their antigen specificity, they recognized GP in an antigen-specific and IgG dose-dependent manner. They remained reactive to GP at the lowest tested concentrations (1.953–7.8 ng/mL). In particular, IgG antibodies from clones D11-3, D12-1, and E140-2 recognized the native forms of GP expressed on the cell surface. These antibodies were identified as IgG1, IgG2a, or IgG2b kappa types and appeared to recognize the native forms of GP, but not the denatured forms of GP, as determined by Western blot assay. Despite their GP-binding activity, none of the IgG antibodies neutralized Ebola virus infection in vitro, suggesting that these antibodies are unable to neutralize Ebola virus infection. CONCLUSION: This study shows that the purified IgG antibodies from 5 clones (C36-1, D11-3, D12-1, D34-2, and E140-2) possess GP-binding activity but not Ebola virus-neutralizing activity.
Animals
;
Antibodies*
;
Antibody Formation
;
Blotting, Western
;
Clone Cells
;
Ebolavirus*
;
Enzyme-Linked Immunosorbent Assay
;
Flow Cytometry
;
Glycoproteins*
;
Hemorrhagic Fever, Ebola
;
Hybridomas
;
Immunoglobulin G*
;
In Vitro Techniques
;
Mice
;
Sensitivity and Specificity
;
Spleen
;
Vaccines
;
Vaccines, DNA
10.Effectiveness of inactivated hantavirus vaccine on the disease severity of hemorrhagic fever with renal syndrome.
Yongjin YI ; Hayne PARK ; Jaehun JUNG
Kidney Research and Clinical Practice 2018;37(4):366-372
BACKGROUND: An inactivated Hantaan virus vaccine (iHV) has been broadly used as a preventive strategy for hemorrhagic fever with renal syndrome (HFRS) by the South Korean Army. After the vaccination program was initiated, the overall incidence of HFRS cases was reduced in the military population. While there are about 400 HFRS cases annually, few studies have demonstrated the efficacy of the iHV in field settings. Therefore, this study aimed to evaluate the iHV efficacy on HFRS severity. METHODS: From 2009 to 2017, HFRS cases were collected in South Korean Army hospitals along with patients’ vaccination history. HFRS patients were classified retrospectively into two groups according to vaccination records: no history of iHV vaccination and valid vaccination. Vaccine efficacy on the severity of acute kidney injury (AKI) stage and dialysis events were investigated. RESULTS: The effects of the iHV on renal injury severity in between 18 valid vaccinated and 110 non-vaccinated patients were respectively evaluated. In the valid vaccination group, six of the 18 HFRS patients (33.3%) had stage 3 AKI, compared to 60 of the 110 (54.5%) patients in the non-vaccination group. The iHV efficacy against disease progression (VEp) was 58.1% (95% confidence interval, 31.3% to 88.0%). CONCLUSION: The iHV efficacy against the progression of HFRS failed to demonstrate statistically significant protection. However, different severity profiles were observed between the iHV and non-vaccination groups. Additional studies with larger populations are needed to demonstrate the effectiveness of the iHV in patients with HFRS.
Acute Kidney Injury
;
Dialysis
;
Disease Progression
;
Hantaan virus
;
Hantavirus*
;
Hemorrhagic Fever with Renal Syndrome*
;
Hospitals, Military
;
Humans
;
Incidence
;
Military Personnel
;
Preventive Medicine
;
Retrospective Studies
;
Vaccination


Result Analysis
Print
Save
E-mail